Figure 1From: Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury Experimental design flowchart showing experimental groups, endpoints, and outcome measures under each experimental arm: (1) CCI injured groups over time compared to craniotomy (control), (2) CCI injured mice treated with vehicle, cannabinoid receptor type 2 (CB 2 R) agonist, (*0-1966 or **JWH-133 (JWH)), or CB 2 R antagonist (SR144528), and (3) wild-type CCI mice treated with vehicle or JWH, compared to CB 2 R knockout CCI injured mice with and without JWH. Back to article page